AzTrials
AzTrials

Peripheral Venous CatheterizationNCT05647889

Pain and Anxiety in Peripheral Venous Catheterization, Jet Lidocaine, Ice Application

A study testing Jet lidocaine, Ice and Standard PVC procedure in people with Peripheral Venous Catheterization, run by Ataturk University at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Investigation of the Effect of Jet Lidocaine and Ice Application on Pain and Anxiety in Peripheral Venous Catheterization (PVC). The research will be carried out experimentally with a single group post-test method. Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Peripheral Venous Catheterization
What is being tested?
Jet lidocaine, Ice and Standard PVC procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
2 sitesTurkey (Türkiye)
Study dates
1 Jun 2022to 1 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Able to speak and understand Turkish,
  • Those between the ages of 18-50,
  • Demanding peripheral venous catheter insertion,
  • Having lidocaine request before PVC,
  • Having no problems with vision and hearing,
  • No history of secondary acute pain other than peripheral venous catheter,
Show all 11Show fewer
  • Having no physical barrier to insertion of a catheter from the cephalic veins,
  • Not allergic to lidocaine and cold,
  • No signs of phlebitis, scar tissue, dermatitis, incision and infection in the area to be operated,
  • No history of peripheral nerve disease, peripheral neuropathy, paresis, plegia or hemiplegia that may affect the sensation of pain,
  • Individuals without coagulation disorder, liver failure, kidney and cardiovascular failure will be included in the study.

Who cannot join

  • Cannot speak or understand Turkish,
  • Those who are outside the age range of 18-50,
  • No request for peripheral venous catheter insertion,
  • No lidocaine request before PVC,
  • Having any problems with vision and hearing,
  • Having a history of any secondary acute pain other than peripheral venous catheter,
Show all 11Show fewer
  • Having a physical obstacle to insertion of a catheter from the cephalic veins,
  • Those who are allergic to lidocaine and cold,
  • With phlebitis, scar tissue, dermatitis, incision and infection findings in the area to be operated,
  • Having a history of peripheral nerve disease, peripheral neuropathy, paresis, plegia or hemiplegia that may affect the sensation of pain,
  • Patients with coagulation disorder, liver failure, kidney and cardiovascular failure

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Ataturk University Faculty of Nursing

    Erzurum, Centre, 25100

  • Gumushane Health Services Vocational School

    Gümüşhane, Centre, 29100

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of the Effect of Jet Lidocaine and Ice Application on Reduction of Pain and Anxiety Related to Peripheral Venous Catheterisation in Adult Patients: A Randomised Controlled Trial

Investigation of the Effect of Jet Lidocaine and Ice Application on Pain and Anxiety in Peripheral Venous Catheterization (PVC). The research will be carried out experimentally with a single group post-test method. The universe of the research; Between June-December 2022, all patients who need peripheral venous catheterization (PVK) for the treatment plan will be formed in the internal clinics of Gümüşhane State Hospital. The sample of the study will consist of 80 patients from the defined population who meet the inclusion criteria. Power analysis was used to determine the number of samples in the study. First of all, patients who are hospitalized in the internal clinics of Gümüşhane State Hospital and who meet the inclusion criteria will be determined. Written and verbal consent will be obtained for their participation by giving information about the research. PVK application will be applied to all patients by the same investigator. Each patient will create their own control group in order to control individual differences in pain and anxiety. In the study consisting of two intervention and a control group; The same patients will be included in the intervention groups and the control group. Randomization will be done to determine the order of intervention to be applied to the patients. The interventions for each patient will be numbered by the researcher and the order of procedure will be determined by drawing lots. After the cephalic vein for the first attempt is randomly determined, the other extremity vein will be used while performing consecutive PVC applications. To control the research in terms of bias; During the data collection phase, help will be taken from the clinical nurse who takes care of the patient. The nurse, who does not know which intervention is applied, will be asked to evaluate the patient's pain and anxiety. In this respect, the research will be considered single-blind.

Read the detailed description

This study was planned as a randomized controlled, single-blind experiment. The research will be carried out in the internal clinics of Gümüşhane State Hospital. Internal clinics were preferred because patients hospitalized in surgical clinics experienced intense pain and anxiety due to surgical operations. The universe of the research; All patients who are hospitalized in the relevant clinics within the specified time period and who need to apply PVC for the treatment plan will be formed.

The sample of the research; It will consist of 80 patients who are hospitalized in internal clinics, who need PVC for diagnosis or treatment, and who meet the research criteria. Power analysis was used to determine the number of samples in the study.The data of the research; Patient Information Form will be collected using the Visual Analog Scale for Pain (VAS-P), Visual Analog Scale for Anxiety (VAS-A), Wong-Baker Faces Pain Rating Scale. Nursing Intervention: The research will be conducted experimentally with a single group post-test method. First of all, patients who meet the criteria for inclusion in the study will be determined, and written and verbal consent will be obtained for their participation by giving information about the research. PVC application will be applied to all patients by the same investigator. Each patient will create their own control group in order to control individual differences in pain and anxiety. In the study consisting of two intervention and a control group; The same patients will be included in the intervention groups and the control group. Randomization will be done to determine the order of intervention to be applied to the patients. Interventions will be numbered for each patient and the order of procedure will be determined by drawing lots. After the cephalic vein for the first attempt is randomly determined, the other extremity vein will be used while performing consecutive PVC applications. To control the research in terms of bias; During the data collection phase, help will be taken from the clinical nurse who takes care of the patient. The nurse, who does not know which intervention is applied, will be asked to evaluate the patient's pain and anxiety. In this respect, the research will be considered single-blind.

Intervention group-I (Jet lidocaine will be applied before PVC and PVC will be performed 3 minutes later) Intervention group-II (Ice application will be made for 1 minute before PVC and then PVC will be performed) It will be named as the control group (Standard PVC procedure will be applied)

Process steps

Control group PVC Application Steps

  1. Hands will be washed.
  2. The treatment tray will be prepared.
  3. The correct patient will be determined, the procedure will be explained to the patient and permission will be obtained.
  4. A "Patient Identification Form" will be applied to the individual before PVC.
  5. The individual will be given a fowler, semi fowler or supine position.
  6. The area where PVC will be applied will be checked for phlebitis, thrombophlebitis, ecchymosis, hematoma and signs of local infection.
  7. The vein to be administered will be evaluated by observing and palpating in terms of intervention.
  8. By wearing gloves, the side grip sections of the peripheral venous catheter (22 G) will be brought to the horizontal position.
  9. A tourniquet will be attached 10-15 cm above the area where the catheter will be entered.
  10. The catheter will be held between the thumb and forefinger with the tapered side of the needle facing up.
  11. The individual will be asked to turn their head in the opposite direction to the side where the peripheral venous catheter will be inserted.
  12. Cleaning of the area will be done with a cotton pad with antiseptic in a single movement in the direction of arterial blood circulation and it will be waited for about 5 seconds for the area to dry.
  13. The catheter will be held at an angle of 30-45° to the skin, approximately 1 cm below the area where the vein is to be entered, and the vein will be accessed.
  14. As soon as the needle enters the vein, it will be slowly advanced into the vein, reducing the angle to approximately 15°.
  15. It will be checked whether there is blood coming to the blood stopper valve and if there is blood, the catheter will continue to be advanced in the vein.
  16. At this stage, the needle of the catheter will be withdrawn with the passive hand, while the plastic part will be advanced into the vein with the active hand simultaneously.
  17. The level of pain related to the PVC application during the insertion of the catheter will be evaluated by the clinical nurse with the Wong-Baker Faces Pain Rating Scale.
  18. Without moving the catheter in the vein, the tourniquet will be loosened with the inactive hand, fixed temporarily with a small patch, the needle of the catheter will be removed and the cap of the catheter will be closed.
  19. Permanent fixation of the catheter will be performed.
  20. Contaminated materials will be removed from the environment.
  21. Within 1 minute after catheter placement, patients' pain and anxiety levels related to PVC application will be evaluated with VAS-A and VAS-P.

Intervention group-I PVC Application Steps

  1. Implementation steps 1-7 of the Control Group will be done.
  2. A tourniquet will be tied 10-15 cm above the area where the catheter will be inserted by wearing gloves.
  3. After the area to be intervened is determined, the tourniquet will be dissolved, the area will be cleaned with a cotton pad with antiseptic from top to bottom in a single movement, and the area will be waited for 5 seconds to dry.
  4. The dermis layer on the vein determined for intervention will be pulled to the side with the help of the passive hand (without any venous intervention), and the head of the lidocaine-loaded jet device will be firmly placed on the cit at an angle of 90°.
  5. Since 0.3 ml of lidocaine solution or 3 mg of total dose will not pose a problem in terms of drug toxicity; 0.3 ml 1% lidocaine will be applied with a Jet device and waited for 5 seconds.
  6. After waiting for 5 seconds, the Jet device will be lifted and the skin will be released.
  7. Catheter intervention will be performed after 3 min to achieve optimal anesthetic conditions.
  8. The lateral grips of the peripheral venous catheter (22 G) will be placed in the horizontal position.
  9. The process will be completed by performing the steps between 9-11 and 13-21 of the Control Group.

Initiative Group-II PVC Application Steps

  1. Implementation steps of the Control Group 1-7 will be done.
  2. In order to create an anesthetic effect; Ice will be applied for 1 minute to the designated area to enter before PVC.
  3. The process will be completed by performing the 8-21 application steps of the Control Group.Variables of the Study Dependent variables were: Visual Analog Scale Score for Anxiety (VAS-A), Visual Analog Scale Score for Pain (VAS-P), and Wong-Baker Faces Pain Rating Scale Score.

Independent variables:

0.3 ml Jet lidocaine application before peripheral venous catheterization

1 minute ice application before peripheral venous catheterization

Control variables:

Peripheral venous catheterization site (Cephalic vein), Catheter diameter and length (22 G)

Evaluation of data: The data will be evaluated in the SPSS (Statistical Package for Social Sciences for Windows, Version 22.0) package program. In the evaluation of the data, the statistical significance value will be accepted as 0.05, the Type 1 error will be kept at 5% and the evaluation will be made with a 95% confidence interval

Being tested
Jet lidocaine, Ice, Standard PVC procedure
Keywords
Pain, Anxiety, Ice application, Jet Lidocaine, Nursing, Peripheral venous catheterization
Medical subject headings
Pain, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Jet lidocaineDrug

    Also called Intervention group-I

    Jet lidocaine will be applied before PVC and PVC will be performed 3 minutes later.

  • IceCombination product

    Also called Intervention group-II

    Ice will be applied for 1 minute before PVC, and then PVC will be performed.

  • Standard PVC procedureOther

    Also called standard application group

    Standard PVC procedure will be applied

Study groups in NCT05647889
Study groupRoleWhat they receive
Jet lidocaine groupExperimentalJet lidocaine will be applied before PVC and PVC will be performed 3 minutes later.
Receives: Drug: Jet lidocaine
Ice groupExperimentalIce will be applied for 1 minute before PVC, and then PVC will be performed.
Receives: Combination Product: Ice
Control groupActive comparatorStandard PVC procedure will be applied
Receives: Other: Standard PVC procedure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analogue Scale for Pain (VAS-P)

    It is a scale used to evaluate the severity of pain. It is a 100 mm ruler with painlessness at one end and the most severe pain at the other. "0" denotes painlessness, and "100" denotes the most severe pain.A low score from the scale indicates that the application is beneficial.

    Measured: Within 1 minute after PVC application

Secondary outcomes (1)
  1. Visual Analogue Scale for Anxiety (VAS-A)

    VAS-A; It consists of a continuous horizontal line 0-100 mm long. "0" represents I am not nervous at all, while "100" represents I am extremely nervous. Participants indicate their level of anxiety by specifying a position between the two extremes.A low score from the scale indicates that the application is beneficial.

    Measured: Within 1 minute after PVC application

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Dec 2022
  2. Study start1 Jun 2022
  3. Primary completion31 Dec 2022
  4. Study completion1 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Sequential
Model description
In the study, 80 individuals, including 2 experimental and 1 control group, were included in the study.
Masking
Single blind
Who is masked
Care provider
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05647889
Sponsor's protocol ID
ATATURKUNIVERSITYESRAAYDIN0029
Status last verified
Apr 2025
First submitted
20 Oct 2022
Last updated
30 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Jet lidocaine, Ice and Standard PVC procedure in people with Peripheral Venous Catheterization, run by Ataturk University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analogue Scale for Pain (VAS-P) (time frame: Within 1 minute after PVC application). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2025; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in